Clinical Trial Update: A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259) [Phase 4]

View source ↗

Summary

This Phase 4 clinical study evaluating rofecoxib for post-operative pain after total knee replacement has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Rofecoxib (rofecoxib)
• Vioxx (rofecoxib)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pain | Phase 4 | Status: TERMINATED